NIH-funded research R01 grant

How cholesterol regulation affects immune responses in heart diseases

Official title: Sterol regulation of immunometabolic responses in cardiometabolic diseases

Funded at Yale University · NIH-11029401 · Data updated 2026-11-12

This study is looking at how changes in cholesterol levels can affect the immune system and contribute to heart diseases like atherosclerosis, and it aims to find new ways to help improve heart health by understanding these connections better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2028
Funding year2025
Award (this year)$787,267
NIH project number1R01HL177553-01
Project IDNIH-11029401 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for or diagnosed with cardiometabolic diseases, particularly those with atherosclerosis.

Less likely to help

Patients who do not have any cardiovascular risk factors or existing heart conditions may not benefit from this research.

What this research studies

This research investigates the role of cholesterol regulation in the immune responses related to cardiometabolic diseases, particularly atherosclerosis. It focuses on how alterations in cholesterol levels can lead to chronic inflammation, which is a key factor in the progression of heart diseases. The study will explore genetic modifications in macrophages to understand their impact on cholesterol metabolism and inflammation. By examining these mechanisms, the research aims to identify potential therapeutic targets for improving cardiovascular health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that reduce inflammation and slow the progression of heart diseases.

How similar studies have gone: Previous research has shown promising results in understanding the role of cholesterol in immune responses, indicating that this approach may lead to significant advancements in treatment.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Fernandez Hernando, Carlos — Yale University
  • Study coordinator: Fernandez Hernando, Carlos

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.